Artificial Intelligence and Stroke Management

As a burgeoning technology, artificial intelligence has been utilized in numerous domains, including stroke prevention, diagnosis, treatment, and rehabilitation, and has demonstrated considerable promise. The combination of artificial intelligence and big data can be utilized for accurate identification of stroke high-risk groups, automatic etiology classification, and assistance in the formulation of acute stroke and secondary prevention strategies, thereby enhancing the rehabilitation treatment effect for stroke patients. This article discusses the accomplishments made in artificial intelligence research for stroke prevention, diagnosis, treatment, and rehabilitation

Advanced Signal Processing in Wearable Sensors for Health Monitoring

Smart, wearables devices on a miniature scale are becoming increasingly widely available, typically in the form of smart watches and other connected devices. Consequently, devices to assist in measurements such as electroencephalography (EEG), electrocardiogram (ECG), electromyography (EMG), blood pressure (BP), photoplethysmography (PPG), heart rhythm, respiration rate, apnoea, and motion detection are becoming more available, and play a significant role in healthcare monitoring. The industry is placing great emphasis on making these devices and technologies available on smart devices such as phones and watches. Such measurements are clinically and scientifically useful for real-time monitoring, long-term care, and diagnosis and therapeutic techniques. However, a pertaining issue is that recorded data are usually noisy, contain many artefacts, and are affected by external factors such as movements and physical conditions. In order to obtain accurate and meaningful indicators, the signal has to be processed and conditioned such that the measurements are accurate and free from noise and disturbances. In this context, many researchers have utilized recent technological advances in wearable sensors and signal processing to develop smart and accurate wearable devices for clinical applications. The processing and analysis of physiological signals is a key issue for these smart wearable devices. Consequently, ongoing work in this field of study includes research on filtration, quality checking, signal transformation and decomposition, feature extraction and, most recently, machine learning-based methods

A Review on Computer Aided Diagnosis of Acute Brain Stroke.

Amongst the most common causes of death globally, stroke is one of top three affecting over 100 million people worldwide annually. There are two classes of stroke, namely ischemic stroke (due to impairment of blood supply, accounting for ~70% of all strokes) and hemorrhagic stroke (due to bleeding), both of which can result, if untreated, in permanently damaged brain tissue. The discovery that the affected brain tissue (i.e., 'ischemic penumbra') can be salvaged from permanent damage and the bourgeoning growth in computer aided diagnosis has led to major advances in stroke management. Abiding to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines, we have surveyed a total of 177 research papers published between 2010 and 2021 to highlight the current status and challenges faced by computer aided diagnosis (CAD), machine learning (ML) and deep learning (DL) based techniques for CT and MRI as prime modalities for stroke detection and lesion region segmentation. This work concludes by showcasing the current requirement of this domain, the preferred modality, and prospective research areas

Intelligent Biosignal Processing in Wearable and Implantable Sensors

This reprint provides a collection of papers illustrating the state-of-the-art of smart processing of data coming from wearable, implantable or portable sensors. Each paper presents the design, databases used, methodological background, obtained results, and their interpretation for biomedical applications. Revealing examples are brain–machine interfaces for medical rehabilitation, the evaluation of sympathetic nerve activity, a novel automated diagnostic tool based on ECG data to diagnose COVID-19, machine learning-based hypertension risk assessment by means of photoplethysmography and electrocardiography signals, Parkinsonian gait assessment using machine learning tools, thorough analysis of compressive sensing of ECG signals, development of a nanotechnology application for decoding vagus-nerve activity, detection of liver dysfunction using a wearable electronic nose system, prosthetic hand control using surface electromyography, epileptic seizure detection using a CNN, and premature ventricular contraction detection using deep metric learning. Thus, this reprint presents significant clinical applications as well as valuable new research issues, providing current illustrations of this new field of research by addressing the promises, challenges, and hurdles associated with the synergy of biosignal processing and AI through 16 different pertinent studies. Covering a wide range of research and application areas, this book is an excellent resource for researchers, physicians, academics, and PhD or master students working on (bio)signal and image processing, AI, biomaterials, biomechanics, and biotechnology with applications in medicine

Computer aided diagnosis of cerebrovascular disease based on DSA image

In recent years, the incidence of cerebrovascular diseases in China has shown a significant upward trend, and it has become a common disease threatening people's lives. Digital Subtraction Angiography (DSA) is the gold standard for the diagnosis of clinical cerebrovascular disease, and it is the most direct method to check the brain lesion. At present, there are the following two problems in the clinical research of DSA images: DSA is a real-time image with numerous frames, containing much useless information in frames; thus, human interpretation and annotation are time-consuming and labor-intensive. The blood vessel structure in DSA images is so complicated that high practical skills are required for clinicians. In the computer-aided diagnosis of DSA sequence images, there is currently a lack of automatic and effective computer-aided diagnosis algorithms for cerebrovascular diseases. Based on the above issues, the main work of this paper is as follows: 1.A multi-target detection algorithm based on Faster-RCNN is designed and applied to the analysis of brain DSA images. The algorithm divides DSA images into arterial phase, capillary phase, pre-venous phase and sinus phase by identifying the main blood vessel structure in each frame. And on this basis, we analyze the time relationship between the time phases. 2.On the basis of DSA phase detection, a key frame location algorithm based on single blood vessel structure detection is designed for moyamoya disease. First, the target detection model is applied to locate the internal carotid artery and the Willis circle. Then, five frames of images are extracted from the arterial period as keyframes. Finally, the nidus' ROI is determined according to the position of the internal carotid artery. 3.A diagnostic method for cerebral arteriovenous malformation (AVM) is designed, which combines temporal features and radiomics features. First, on the basis of DSA time phase detection, we propose a deep learning network to extract vascular time features from the DSA video; then, the time feature is combined with the radiomics features of the static keyframe to establish an AVM diagnosis model. While assisting diagnosis, this method does not require any human intervention, and reduces the workload of clinicians. The diagnostic model that combines time features and radiomics features is applied to the study of AVM staging. The experimental results prove that the classification model trained by fusion features has better diagnostic performance than the model trained by either time features or radiomics features. Based on the above three parts, this paper establishes a cerebrovascular disease analysis framework based on radiomics method and deep learning. We introduce corresponding solutions for DSA automatic image reading, rapid diagnosis of moyamoya disease, and precise diagnosis of AVM. The method proposed in this paper has practical significance for assisting the diagnosis of cerebrovascular disease and reducing the burden of medical staff.Digital Subtraction Angiography(DSA), Radiomics analysis, Arteriovenous malformations, Moyamoya, Faster-RCNN, Temporal features, Fusion feature

Machine Learning for Biomedical Application

Biomedicine is a multidisciplinary branch of medical science that consists of many scientific disciplines, e.g., biology, biotechnology, bioinformatics, and genetics; moreover, it covers various medical specialties. In recent years, this field of science has developed rapidly. This means that a large amount of data has been generated, due to (among other reasons) the processing, analysis, and recognition of a wide range of biomedical signals and images obtained through increasingly advanced medical imaging devices. The analysis of these data requires the use of advanced IT methods, which include those related to the use of artificial intelligence, and in particular machine learning. It is a summary of the Special Issue “Machine Learning for Biomedical Application”, briefly outlining selected applications of machine learning in the processing, analysis, and recognition of biomedical data, mostly regarding biosignals and medical images

Human treelike tubular structure segmentation: A comprehensive review and future perspectives

Various structures in human physiology follow a treelike morphology, which often expresses complexity at very fine scales. Examples of such structures are intrathoracic airways, retinal blood vessels, and hepatic blood vessels. Large collections of 2D and 3D images have been made available by medical imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), Optical coherence tomography (OCT) and ultrasound in which the spatial arrangement can be observed. Segmentation of these structures in medical imaging is of great importance since the analysis of the structure provides insights into disease diagnosis, treatment planning, and prognosis. Manually labelling extensive data by radiologists is often time-consuming and error-prone. As a result, automated or semi-automated computational models have become a popular research field of medical imaging in the past two decades, and many have been developed to date. In this survey, we aim to provide a comprehensive review of currently publicly available datasets, segmentation algorithms, and evaluation metrics. In addition, current challenges and future research directions are discussed

Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson’s Disease Affected by COVID‐19: A Narrative Review

Background and Motivation: Parkinson’s disease (PD) is one of the most serious, non-curable, and expensive to treat. Recently, machine learning (ML) has shown to be able to predict cardiovascular/stroke risk in PD patients. The presence of COVID‐19 causes the ML systems to be-come severely non‐linear and poses challenges in cardiovascular/stroke risk stratification. Further, due to comorbidity, sample size constraints, and poor scientific and clinical validation techniques, there have been no well‐explained ML paradigms. Deep neural networks are powerful learning machines that generalize non‐linear conditions. This study presents a novel investigation of deep learning (DL) solutions for CVD/stroke risk prediction in PD patients affected by the COVID‐19 framework. Method: The PRISMA search strategy was used for the selection of 292 studies closely associated with the effect of PD on CVD risk in the COVID‐19 framework. We study the hypothesis that PD in the presence of COVID‐19 can cause more harm to the heart and brain than in non‐ COVID‐19 conditions. COVID‐19 lung damage severity can be used as a covariate during DL training model designs. We, therefore, propose a DL model for the estimation of, (i) COVID‐19 lesions in computed tomography (CT) scans and (ii) combining the covariates of PD, COVID‐19 lesions, office and laboratory arterial atherosclerotic image‐based biomarkers, and medicine usage for the PD patients for the design of DL point‐based models for CVD/stroke risk stratification. Results: We validated the feasibility of CVD/stroke risk stratification in PD patients in the presence of a COVID‐ 19 environment and this was also verified. DL architectures like long short‐term memory (LSTM), and recurrent neural network (RNN) were studied for CVD/stroke risk stratification showing powerful designs. Lastly, we examined the artificial intelligence bias and provided recommendations for early detection of CVD/stroke in PD patients in the presence of COVID‐19. Conclusion: The DL is a very powerful tool for predicting CVD/stroke risk in PD patients affected by COVID‐19. © 2022 by the authors. Licensee MDPI, Basel, Switzerland

Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson’s Disease Affected by COVID‐19: A Narrative Review

Background and Motivation: Parkinson’s disease (PD) is one of the most serious, non-curable, and expensive to treat. Recently, machine learning (ML) has shown to be able to predict cardiovascular/stroke risk in PD patients. The presence of COVID‐19 causes the ML systems to be-come severely non‐linear and poses challenges in cardiovascular/stroke risk stratification. Further, due to comorbidity, sample size constraints, and poor scientific and clinical validation techniques, there have been no well‐explained ML paradigms. Deep neural networks are powerful learning machines that generalize non‐linear conditions. This study presents a novel investigation of deep learning (DL) solutions for CVD/stroke risk prediction in PD patients affected by the COVID‐19 framework. Method: The PRISMA search strategy was used for the selection of 292 studies closely associated with the effect of PD on CVD risk in the COVID‐19 framework. We study the hypothesis that PD in the presence of COVID‐19 can cause more harm to the heart and brain than in non‐ COVID‐19 conditions. COVID‐19 lung damage severity can be used as a covariate during DL training model designs. We, therefore, propose a DL model for the estimation of, (i) COVID‐19 lesions in computed tomography (CT) scans and (ii) combining the covariates of PD, COVID‐19 lesions, office and laboratory arterial atherosclerotic image‐based biomarkers, and medicine usage for the PD patients for the design of DL point‐based models for CVD/stroke risk stratification. Results: We validated the feasibility of CVD/stroke risk stratification in PD patients in the presence of a COVID‐ 19 environment and this was also verified. DL architectures like long short‐term memory (LSTM), and recurrent neural network (RNN) were studied for CVD/stroke risk stratification showing powerful designs. Lastly, we examined the artificial intelligence bias and provided recommendations for early detection of CVD/stroke in PD patients in the presence of COVID‐19. Conclusion: The DL is a very powerful tool for predicting CVD/stroke risk in PD patients affected by COVID‐19

Epilepsy

With the vision of including authors from different parts of the world, different educational backgrounds, and offering open-access to their published work, InTech proudly presents the latest edited book in epilepsy research, Epilepsy: Histological, electroencephalographic, and psychological aspects. Here are twelve interesting and inspiring chapters dealing with basic molecular and cellular mechanisms underlying epileptic seizures, electroencephalographic findings, and neuropsychological, psychological, and psychiatric aspects of epileptic seizures, but non-epileptic as well